.jpg)
Speaking at the IMC Bharat Calling conference, Meenakshi Nevatia, Country President & Managing Director, Pfizer India, shared her views on how India is a key player in pharma innovation through advanced manufacturing, clinical trials...
Novo Nordisk has made the complete SOUL results presentation today, the results from a 3-phase cardiovascular outcomes study indicated that oral semaglutide significantly decreased the risk of major adverse cardiovascular events in adults with...
The anti-obesity drug market in India experienced a remarkable fourfold increase from March 2021 to March 2025 according to PharmaTrac data with a value growth from ?133 crore to ?576 crore. The market points to lifestyle disorders as well as consume
Researchers at the University of South Australia (UniSA) are working on a laparoscopic probe that uses quantum technology to enhance the detection of gastrointestinal cancers. Supported by the federal government's Economic Accelerator...
The World Health Organization (WHO) has officially re-designated the Medicines and Healthcare products Regulatory Agency's (MHRA) Science and Research group as a Collaborating Centre for the Standardisation and Evaluation of Biologicals for...
A “next-generation” delivery system has been launched by Abbott to streamline the electrode implantation process for its Proclaim DRG neurostimulation system.
A multidisciplinary team of scientists from Northwestern University has created new technology that could result in the development of an HIV infection point-of-care test that is competitive with conventional lab-based HIV testing in a fraction....
Supported by the Cancer Grand Challenges program, the SAMBAI team has chosen the Akoya Biosciences PhenoCycler-Fusion as their primary spatial proteomics technology for the...
Honeywell has introduced TrackWise Manufacturing, an AI-powered, cloud-based software designed to transform how life sciences organizations manage, automate, and digitize their businesses...
At the European Lung Cancer Congress (ELCC) 2025, AstraZeneca showcased new research that showed how artificial intelligence (AI) could enhance lung cancer risk detection, particularly in healthcare settings with limited resources.
, CDSCO.jpg)
